Petros Pharmaceuticals In... (PTPI)

AI Score

Unlock

0.05

-0.00 (-2.34%)

At close: Apr 25, 2025, 3:59 PM

Petros Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	3.71M	3.89M	7.46M	11.08M	13.34M	17.97M	7.38M	8.32M	9.43M	11.18M	13.3M	17.67M	23.85M	8.14M	11.03M	14.57M	17.14M	669.08K	831.76K	1.14M	2.15M	-2.79M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.59M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	3M	3.47M	3.94M	4.18M	4.42M	4.65M	4.88M	5.11M	5.34M	5.56M	4.8M	11.03M	11.14M	11.14M	11.14M	11.14M	6.57M	6.73M	6.73M	6.73M	-2.79M
Receivables	416.08K	1.95M	1.78M	1.96M	2.23M	2.98M	2.58M	2.4M	2.11M	3.73M	5.75M	3.74M	2.46M	1.95M	2.02M	6.19M	5.15M	4.15M	1.11M	4.08M	2.61M	n/a
Inventory	1.35M	1.41M	1.43M	1.56M	1.61M	2.5M	2.18M	2.04M	1.82M	2.15M	1.91M	1.94M	519.65K	518.48K	439.23K	560.86K	760.53K	1.57M	1.79M	1.95M	2.2M	n/a
Other Current Assets	6.53K	1.65M	1.27M	1.03M	816.21K	751.88K	715.8K	71.74K	802.21K	797.76K	788.92K	1.5M	2.14M	1.92M	1.44M	1.41M	1.48M	2.34M	2.1M	2.42M	3.57M	n/a
Total Current Assets	7.29M	10.72M	13.98M	17.9M	20.39M	24.43M	13.15M	13.9M	14.67M	18.77M	22.85M	26.84M	30.54M	13.35M	16.23M	23.96M	25.91M	10.45M	6.87M	10.91M	12.09M	2.79M
Property-Plant & Equipment	136.68K	143.75K	177.59K	216.97K	255.22K	292.36K	328.46K	363.54K	397.65K	430.81K	463.07K	494.44K	524.95K	554.65K	583.56K	611.44K	643.78K	670.51K	696.36K	721.75K	742.08K	n/a
Goodwill & Intangibles	3.2M	6.83M	7.54M	8.26M	8.97M	9.77M	10.6M	11.42M	12.24M	13.16M	22.18M	23.73M	25.29M	26.98M	28.71M	30.43M	32.16M	33.83M	35.49M	37.15M	38.81M	n/a
Total Long-Term Assets	3.34M	9.97M	11.19M	12.41M	13.41M	14.48M	15.58M	16.67M	17.75M	18.92M	28.2M	29.03M	36.85M	38.68M	40.44M	42.19M	43.95M	41.07M	42.92M	44.6M	46.28M	-2.79M
Total Assets	10.64M	20.69M	25.17M	30.31M	33.8M	38.91M	28.73M	30.57M	32.42M	37.7M	51.05M	55.86M	67.39M	52.04M	56.67M	66.15M	69.85M	51.53M	49.79M	55.51M	58.37M	n/a
Account Payables	2.33M	1.6M	791.09K	2.14M	1.71M	1.36M	1.78M	1.86M	1.81M	1.95M	1.9M	3.7M	4.56M	5.31M	2.6M	5.28M	5.61M	8.3M	5.7M	5.13M	3.78M	n/a
Deferred Revenue	1.91M	1.74M	n/a	-1.55M	2.05M	1.37M	4.78M	n/a	n/a	4.48M	n/a	n/a	-7.15B	25.8M	27.97M	29.59M	28.89M	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	7.25M	2.33M	1.94M	1.55M	1.16M	1.14M	1.12M	1.11M	1.09M	906.09K	904.84K	723.98K	n/a	1.74M	3.43M	5.06M	7.18M	24.39M	21.17M	7.15M	6.68M	n/a
Other Current Liabilities	15.73K	854.76K	5.3M	4.93M	4.55M	3.05M	2.71M	2.38M	822.39K	3.94M	3.52M	4.12M	22.93M	22.71M	25.08M	26.12M	26.15M	20.22M	20.92M	22.09M	22.63M	n/a
Total Current Liabilities	18.03M	12.56M	9.98M	11.22M	10.77M	8.08M	7.97M	6.89M	7.07M	7.94M	7.38M	10.29M	30.98M	33.5M	34.49M	40.22M	41.89M	56.79M	51.7M	43.32M	41.1M	n/a
Long-Term Debt	n/a	4.92M	5.7M	6.46M	6.86M	7.25M	7.63M	8.01M	8.39M	8.76M	9.12M	9.48M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.13M	7.06M	n/a
Other Long-Term Liabilities	n/a	91.83K	202K	1.94M	3.55M	16.38M	1.00	n/a	n/a	1.00	n/a	n/a	460K	250K	2.69M	5.01M	10.49M	1.31M	1.32M	1.51M	1.54M	n/a
Total Long-Term Liabilities	75.22K	5.01M	6.01M	8.4M	10.55M	23.78M	7.82M	8.24M	8.65M	9.06M	9.46M	9.85M	865.02K	687.75K	2.69M	5.01M	10.49M	1.87M	1.91M	10.26M	9.24M	n/a
Total Liabilities	18.1M	17.58M	15.98M	19.62M	21.32M	31.86M	15.78M	15.12M	15.72M	17M	16.83M	20.14M	31.85M	34.19M	37.18M	45.23M	52.38M	58.66M	53.62M	53.58M	50.35M	n/a
Total Debt	7.39M	7.25M	7.63M	8.01M	8.28M	8.69M	8.94M	9.34M	9.88M	9.96M	10.36M	10.57M	405.02K	2.18M	3.43M	5.06M	7.18M	24.95M	21.76M	15.89M	14.38M	n/a
Common Stock	1.05K	1M	930.00	688.00	298.00	211.00	211.00	209.00	208.00	2.07K	2.07K	2.07K	2.07K	983.00	983.00	980.00	971.00	29.12M	29.12M	29.12M	29.12M	n/a
Retained Earnings	-113.21M	-103.93M	-101.71M	-101.05M	-98.89M	-99.21M	-94.66M	-92.11M	-90.73M	-86.51M	-72.67M	-70.86M	-70.69M	-62.5M	-60.81M	-58.69M	-61.7M	-56.26M	-52.96M	-47.2M	-41.12M	n/a
Comprehensive Income	n/a	n/a	n/a	-906.98K	n/a	-124.53K	0.00	n/a	n/a	n/a	n/a	n/a	0.00	0.00	-0.00	0.00	-0.00	n/a	n/a	n/a	n/a	-1.68M
Shareholders Equity	-7.47M	3.12M	9.19M	9.79M	12.48M	6.93M	12.94M	15.45M	16.7M	20.69M	34.22M	35.73M	35.54M	17.85M	19.49M	20.92M	17.47M	-7.13M	-3.83M	1.94M	8.02M	-1.68M
Total Investments	n/a	-3.89B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.59M